Stock Report

All about this stock under one free report Last Updated: 30-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Molbio Diagnostics Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: MOLBIO | BSE: 544866

₹1,094.75

up-down-arrow ₹-49.40 (-4.32%)

As on 28-Aug-2026IST

Market cap

info icon

₹12,646 Cr

Revenue (TTM)

info icon

₹1,446 Cr

P/E Ratio

info icon

75.9

P/B Ratio

info icon

9.2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 41.68 63.22 --
EBIT -- -- 18.44 182.45 --
Net Profit -- -- 18.45 267.53 --
EPS -- -- 14.85 513.94 --
Book Value -- -- 20.79 17.46 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 20.75--17.8321.3323.09
Net Margin info 11.57--11.2813.489.94
Return on equity info 13.88--15.3615.4710.82
Return on Capital info 18.62--19.7920.3015.77
Return on Assets info 9.17--9.3510.637.54
Debt to Equity (x) info ----0.350.130.21

Profitability

View Detailed Peer Comparison

ROCE

19.79

Lower than Peers by 0.12

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
19.79
20.30
15.77
1.97
--
Peer Median
19.91
20.26
19.83
33.53
--
ROE

15.36

Higher than Peers by 0.12

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
15.36
15.47
10.82
-0.48
--
Peer Median
15.24
13.93
15.80
26.65
--
ROA

9.35

Lower than Peers by 0.21

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
9.35
10.63
7.54
-0.34
--
Peer Median
9.56
10.00
8.30
16.54
--
EBIT Margin

17.83

Lower than Peers by 2.73

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
17.83
21.33
23.09
3.44
--
Peer Median
20.56
19.66
18.70
19.68
--
Net Margin

11.28

Lower than Peers by 0.49

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
11.28
13.48
9.94
-1.02
--
Peer Median
11.77
11.96
12.26
16.78
--
Cash Profit Margin

15.76

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
15.76
17.95
14.89
8.51
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

41.68

Higher than Peers by 20.14

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
41.68
21.98
151.63
--
--
Peer Median
21.53
15.74
13.67
4.18
--
EBIT Growth

18.44

Lower than Peers by 5.20

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
18.44
12.68
1,588.43
--
--
Peer Median
23.64
22.60
11.16
-14.65
--
Net Profit Growth

18.45

Lower than Peers by 4.49

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
18.45
65.88
2,525.02
--
--
Peer Median
22.94
23.29
9.39
-16.12
--
EPS Growth

14.85

Higher than Peers by 12.99

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
14.85
42.20
--
--
--
Peer Median
1.87
29.43
-7.32
-35.05
--
Book Value Growth

20.75

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
20.75
17.66
14.13
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.35

Higher than Peers by 0.33

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
0.35
0.13
0.21
0.15
--
Peer Median
0.02
0.05
0.08
0.15
--
Short term debt to equity ratio

0.15

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
0.15
0.11
0.18
0.15
--
Peer Median
--
--
--
--
--
Current Ratio

2.48

Lower than Peers by 0.06

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
2.48
2.11
2.40
2.37
--
Peer Median
2.54
2.42
2.28
1.88
--
Quick Ratio

1.68

Lower than Peers by 0.89

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
1.68
1.12
1.48
1.03
--
Peer Median
2.57
2.37
2.33
1.78
--
Interest Coverage

7.91

Lower than Peers by 0.05

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
7.91
12.01
9.97
2.39
--
Peer Median
7.95
7.61
10.16
11.52
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

28.27

Higher than Peers by 18.90

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
28.27
26.62
50.86
56.77
--
Peer Median
9.37
10.62
7.60
14.45
--
Asset Turnover

0.82

Lower than Peers by 0.04

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
0.82
0.78
0.76
0.32
--
Peer Median
0.87
0.81
0.77
0.86
--
Receivable days

85.89

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
85.89
124.68
133.99
207.23
--
Peer Median
--
--
--
--
--
Inventory Days

111.74

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
111.74
134.33
144.45
380.98
--
Peer Median
--
--
--
--
--
Payable days

136.11

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
136.11
142.62
96.23
217.88
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

61.52

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
61.52
116.38
182.21
370.33
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
--
--
--
--
--
Peer Median
65.79
59.48
60.28
46.86
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
--
--
--
--
--
Peer Median
8.89
9.63
8.84
6.59
--
EV/EBITDA

0.17

Lower than Peers by 48.71

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
0.17
-0.01
0.65
2.15
--
Peer Median
48.88
48.17
47.88
27.71
--
Market Cap

--

--

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Molbio Diagnostics
--
--
--
--
--
Peer Median
12,422
8,622
9,694
5,629
--
loading...
loading...
loading...
loading...